Your browser doesn't support javascript.
loading
Performance of the 2017 EULAR/ACR criteria for idiopathic inflammatory myopathies in a cohort of patients from Latin America.
Valenzuela, Antonia; Torres, Magdalena; Devés, José Domingo.
Afiliação
  • Valenzuela A; Department of Rheumatology and Clinical Immunology, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
  • Torres M; School of Medicine, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
  • Devés JD; School of Medicine, Pontificia Universidad Católica de Chile, Santiago de Chile, Chile.
Medicine (Baltimore) ; 101(43): e31015, 2022 Oct 28.
Article em En | MEDLINE | ID: mdl-36316860
We aimed to determine the performance of the 2017 European League Against Rheumatism/American College of Rheumatology (EULAR/ACR) classification criteria for idiopathic inflammatory myopathies (IIMs) in a cohort of Chilean patients. This single-center retrospective study included 151 patients with a clinical diagnosis of IIM. Patients were classified according to the 2017 EULAR/ACR classification criteria for IIM, and its performance was compared to the Bohan & Peter (B&P) classification criteria. A total of 135 patients (89.4%) met the EULAR/ACR criteria, and 140 (92.7%) patients met the B&P criteria. A total of 130 patients had IIM according to both the criteria; concordance rate was 29.2% for definite IIM, 6.2% for probable IIM, and 1.5% for possible IIM. The kappa coefficient of agreement was weak between the 2 classification criteria (κ = 0.39, SD 0.15-0.64). Against gold standard expert physician's diagnosis, sensitivity, and specificity of EULAR/ACR criteria was 0.86 and 0.85 to diagnose dermatomyositis, respectively, and 0.73 and 0.87 to diagnose polymyositis. The EULAR/ACR criteria showed good sensitivity and identified more patients with probable or definite IIM than the B&P criteria in a single-center cohort of patients with IIM in South America. The sensitivity of the EULAR/ACR criteria was slightly higher in patients with dermatomyositis, but lower in patients with polymyositis, than that of the B&P criteria.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reumatologia / Doenças Reumáticas / Doenças do Colágeno / Dermatomiosite / Miosite Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: America do sul / Chile Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Chile País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Reumatologia / Doenças Reumáticas / Doenças do Colágeno / Dermatomiosite / Miosite Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans País/Região como assunto: America do sul / Chile Idioma: En Revista: Medicine (Baltimore) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Chile País de publicação: Estados Unidos